RxDoctor Payments Data

Eugene Wolf

Orthopaedic Surgery · San Francisco, CANPI 1386683621

Payments from drug & device makers

What this record shows

This record is dominated by royalties or licence payments: $987,854 of the $988,011 with a category attached, or 100.0%. Arthrex accounts for 100.0% of it on its own, with 1 other manufacturer making up the rest. Reporting peaked in 2019 at $546,291 and has fallen 90.2% since, to $53,415 in 2021. Among orthopaedic surgery clinicians in CA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$988,011in general payments, 2019–2025

Across 11 payments — averaging $89,819 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Arthrex$988K
  • Stryker$157

What the payments were for

  • Royalty or licence$987,854100%
  • Food & beverage$1570%

General payments by program year

19
20
21

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Arthrex9$987,854
Stryker2$157

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$988,011 in reported general payments places this provider in the 95th percentile of 1,808 orthopaedic surgery providers in California.

See all orthopaedic surgery providers in California

Other orthopaedic surgery in San Francisco

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →